Fibrates in CVD: a step towards personalised medicine

Lancet. 2010 May 29;375(9729):1847-8. doi: 10.1016/S0140-6736(10)60758-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Clofibric Acid / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypolipidemic Agents / therapeutic use*
  • PPAR alpha / agonists

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • PPAR alpha
  • Clofibric Acid